Equasens Société anonyme (EPA:EQS)
France
· Delayed Price · Currency is EUR 37.70
+1.05 (2.86%)
At close: Mar 9, 2026
Equasens Société anonyme Revenue
Equasens Société anonyme had revenue of 115.97M EUR in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to 224.73M, up 3.34% year-over-year. In the year 2024, Equasens Société anonyme had annual revenue of 216.75M, down -1.38%.
Revenue (ttm)
224.73M
Revenue Growth
+3.34%
P/S Ratio
2.52
Revenue / Employee
160.52K
Employees
1,400
Market Cap
566.67M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 216.75M | -3.04M | -1.38% |
| Dec 31, 2023 | 219.79M | 5.71M | 2.67% |
| Dec 31, 2022 | 214.08M | 21.01M | 10.88% |
| Dec 31, 2021 | 193.07M | 21.32M | 12.41% |
| Dec 31, 2020 | 171.75M | 13.19M | 8.31% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 28.49B |
| Sanofi | 46.72B |
| Sartorius Stedim Biotech | 2.97B |
| Ipsen | 3.93B |
| Inventiva | 16.97M |
| Vetoquinol | 532.39M |
| Valneva SE | 179.91M |
| MedinCell | 32.44M |